Blog

22 February 2019 - Otsuka and Lundbeck announce that Health Canada issued a Notice of Compliance for Rexulti (brexpiprazole) for ...

20 February 2019 - The approval marks Humira as the only approved biologic treatment option in Canada for paediatric patients from ...

18 February 2019 - Health Canada has announced that all biologics, including biosimilars, will be identified by their brand names and ...

19 February 2019 - Yescarta is a chimeric antigen receptor T-cell therapy that is custom-made for each patient from his or ...

11 February 2019 - Conditional approval validates Idhifa as the first and only oral, targeted inhibitor of IDH2. ...

7 February 2019 - First ever approved peptide receptor radionuclide therapy in Canada. ...

28 January 2019 - Kalydeco is the first and only approved medicine in Canada to treat the underlying cause of ...

[:content [\B \a \c \k \space \o \n \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \8 \, \space \t \h \e \space \U \S \space \F \D \A \space \a \c \c \e \p \t \e \d \space \T \a \n \v \e \x \space \B \i \o \P \h \a \r \m \a \’ \s \space \b \i \o \l \o \g \i \c \s \space \l \i \c \e \n \s \e \space \a \p \p \l \i \c \a \t \i \o \n \space \f \o \r \space \T \X \- \0 \1 \space \( \f \i \l \g \r \a \s \t \i \m \) \, \space \a \space \p \r \o \p \o \s \e \d \space \b \i \o \s \i \m \i \l \a \r \space \t \o " ..."]]

25 January 2019 - Acerus Pharmaceuticals is today advising that it has received a Notice of Deficiency-Withdrawal Letter for its ...

21 January 2019 - Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic ...

15 January 2019 - New treatment option for estimated 100,000 Canadians living with Parkinson's disease. ...

15 January 2019 - Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link ...

14 January 2019 - Astellas today announced that Health Canada approved an expanded indication for enzalutamide, an androgen receptor inhibitor for ...

3 January 2019 - Bausch & Lomb today announced that on 27 December 2018, Health Canada issued the notice of compliance ...